| Source: |
| Type: |
| LOX-1 (Lectin-like oxidized low-density lipoprotein receptor 1) is a protein that has been implicated in various diseases, including cancer. Research has shown that LOX-1 is overexpressed in several types of cancer, including breast, lung, colon, and prostate cancer. LOX-1 is involved in the regulation of cell proliferation, apoptosis (cell death), and angiogenesis (the formation of new blood vessels). In cancer, LOX-1 can promote tumor growth and metastasis by: Enhancing cell proliferation and survival Inhibiting apoptosis Promoting angiogenesis Facilitating the migration and invasion of cancer cells Studies have also shown that LOX-1 can interact with other molecules involved in cancer progression, such as vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs). Inhibiting LOX-1 has been proposed as a potential therapeutic strategy for cancer treatment. |
| Lung CSC (Cancer Stem Cells) markers (CD133, CD44, ALDHA1, Nanog and Oct4) |
| 432- | CUR, | Curcumin-Induced Global Profiling of Transcriptomes in Small Cell Lung Cancer Cells |
| - | in-vitro, | Lung, | H446 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:15 Cells:% prod#:% Target#:680 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid